Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
35,935,120
-
Shares change
-
+403,126
-
Total reported value, excl. options
-
$2,125,191,869
-
Value change
-
-$1,056,901
-
Put/Call ratio
-
96.59%
-
Number of buys
-
91
-
Number of sells
-
-78
-
Price
-
$59.15
Significant Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2018
213 filings reported holding PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock as of Q2 2018.
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,935,120 shares
of 49,633,071 outstanding shares and own 72.4% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (3,302,021 shares), VANGUARD GROUP INC (2,733,799 shares), ORBIMED ADVISORS LLC (2,732,881 shares), BlackRock Inc. (2,505,710 shares), Consonance Capital Management LP (2,089,117 shares), STATE STREET CORP (1,971,243 shares), FMR LLC (1,720,294 shares), Partner Fund Management, L.P. (1,596,783 shares), venBio Select Advisor LLC (1,034,375 shares), and JENNISON ASSOCIATES LLC (950,998 shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.